Highlights

array(40) {
  [0]=>
  string(4) "8671"
  ["article_id"]=>
  string(4) "8671"
  [1]=>
  string(65) "AstraZeneca Joins RNAi Mix, Pledging $80M to Silence Therapeutics"
  ["article_title"]=>
  string(65) "AstraZeneca Joins RNAi Mix, Pledging $80M to Silence Therapeutics"
  [2]=>
  string(150) "After years of research, technology for silencing a gene—stopping it from producing a disease-causing protein—has reached patients. AstraZ"
  ["short_description"]=>
  string(150) "After years of research, technology for silencing a gene—stopping it from producing a disease-causing protein—has reached patients. AstraZ"
  [3]=>
  string(425) "After years of research, technology for silencing a gene—stopping it from producing a disease-causing protein—has reached patients. AstraZeneca is now angling for a position in this burgeoning field through an alliance with Silence Therapeutics, a biotech developing such gene-silencing drugs. According to deal terms announced Wednesday, AstraZeneca (NYSE: AZN) will pay London-based Silence (LON: SLN) […]"
  ["description"]=>
  string(425) "After years of research, technology for silencing a gene—stopping it from producing a disease-causing protein—has reached patients. AstraZeneca is now angling for a position in this burgeoning field through an alliance with Silence Therapeutics, a biotech developing such gene-silencing drugs. According to deal terms announced Wednesday, AstraZeneca (NYSE: AZN) will pay London-based Silence (LON: SLN) […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(102) "https://xconomy.com/europe/2020/03/25/astrazeneca-joins-rnai-mix-pledging-80m-to-silence-therapeutics/"
  ["blog_url"]=>
  string(102) "https://xconomy.com/europe/2020/03/25/astrazeneca-joins-rnai-mix-pledging-80m-to-silence-therapeutics/"
  [15]=>
  string(19) "2020-03-26 03:00:52"
  ["add_date"]=>
  string(19) "2020-03-26 03:00:52"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:33"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

AstraZeneca Joins RNAi Mix, Pledging $80M to Silence Therapeutics

After years of research, technology for silencing a gene—stopping it from producing a disease-causing protein̵

array(40) {
  [0]=>
  string(4) "8633"
  ["article_id"]=>
  string(4) "8633"
  [1]=>
  string(72) "Ultrasound solves an important clinical problem in diagnosing arrhythmia"
  ["article_title"]=>
  string(72) "Ultrasound solves an important clinical problem in diagnosing arrhythmia"
  [2]=>
  string(150) "Researchers have used an ultrasound technique they pioneered a decade ago -- electromechanical wave imaging (EWI) -- to accurately localize atrial and"
  ["short_description"]=>
  string(150) "Researchers have used an ultrasound technique they pioneered a decade ago -- electromechanical wave imaging (EWI) -- to accurately localize atrial and"
  [3]=>
  string(489) "Researchers have used an ultrasound technique they pioneered a decade ago -- electromechanical wave imaging (EWI) -- to accurately localize atrial and ventricular cardiac arrhythmias in adult patients in a double-blinded clinical study. They evaluated the accuracy of EWI for localization of various arrhythmias in all four chambers of the heart prior to catheter ablation: the results showed that EWI correctly predicted 96% of arrhythmia locations as compared with 71% for 12-lead ECGs. "
  ["description"]=>
  string(489) "Researchers have used an ultrasound technique they pioneered a decade ago -- electromechanical wave imaging (EWI) -- to accurately localize atrial and ventricular cardiac arrhythmias in adult patients in a double-blinded clinical study. They evaluated the accuracy of EWI for localization of various arrhythmias in all four chambers of the heart prior to catheter ablation: the results showed that EWI correctly predicted 96% of arrhythmia locations as compared with 71% for 12-lead ECGs. "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "29"
  ["rss_id"]=>
  string(2) "29"
  [14]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200325143828.htm"
  ["blog_url"]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200325143828.htm"
  [15]=>
  string(19) "2020-03-26 02:38:28"
  ["add_date"]=>
  string(19) "2020-03-26 02:38:28"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:27"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:27"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Ultrasound solves an important clinical problem in diagnosing arrhythmia

Researchers have used an ultrasound technique they pioneered a decade ago -- electromechanical wave imaging (EWI) -- to

array(40) {
  [0]=>
  string(4) "8634"
  ["article_id"]=>
  string(4) "8634"
  [1]=>
  string(78) "Computational human cell reveals new insight on genetic information processing"
  ["article_title"]=>
  string(78) "Computational human cell reveals new insight on genetic information processing"
  [2]=>
  string(150) "Researchers have developed the first computational model of a human cell and simulated its behavior for 15 minutes -- the longest time achieved for a "
  ["short_description"]=>
  string(150) "Researchers have developed the first computational model of a human cell and simulated its behavior for 15 minutes -- the longest time achieved for a "
  [3]=>
  string(390) "Researchers have developed the first computational model of a human cell and simulated its behavior for 15 minutes -- the longest time achieved for a biological system of this complexity. In a new study, simulations reveal the effects of spatial organization within cells on some of the genetic processes that control the regulation and development of human traits and some human diseases. "
  ["description"]=>
  string(390) "Researchers have developed the first computational model of a human cell and simulated its behavior for 15 minutes -- the longest time achieved for a biological system of this complexity. In a new study, simulations reveal the effects of spatial organization within cells on some of the genetic processes that control the regulation and development of human traits and some human diseases. "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "29"
  ["rss_id"]=>
  string(2) "29"
  [14]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200325143817.htm"
  ["blog_url"]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200325143817.htm"
  [15]=>
  string(19) "2020-03-26 02:38:17"
  ["add_date"]=>
  string(19) "2020-03-26 02:38:17"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:27"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:27"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Computational human cell reveals new insight on genetic information processing

Researchers have developed the first computational model of a human cell and simulated its behavior for 15 minutes -- th

array(40) {
  [0]=>
  string(4) "8744"
  ["article_id"]=>
  string(4) "8744"
  [1]=>
  string(64) "HP Offers 3D Printing to Increase Production of Critical Devices"
  ["article_title"]=>
  string(64) "HP Offers 3D Printing to Increase Production of Critical Devices"
  [2]=>
  string(158) "&#nl        PALO ALTO, CA — HP Inc. and its global digital manufacturing community are mobilizing 3D printing teams, technology, experience and product"
  ["short_description"]=>
  string(158) "&#nl        PALO ALTO, CA — HP Inc. and its global digital manufacturing community are mobilizing 3D printing teams, technology, experience and product"
  [3]=>
  string(266) "&#nl        PALO ALTO, CA — HP Inc. and its global digital manufacturing community are mobilizing 3D printing teams, technology, experience and production capacity to help deliver critical parts in medical facilities treating patients with COVID-19.&#nl      "
  ["description"]=>
  string(266) "&#nl        PALO ALTO, CA — HP Inc. and its global digital manufacturing community are mobilizing 3D printing teams, technology, experience and production capacity to help deliver critical parts in medical facilities treating patients with COVID-19.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "99"
  ["rss_id"]=>
  string(2) "99"
  [14]=>
  string(107) "https://www.assemblymag.com/articles/95567-hp-offers-3d-printing-to-increase-production-of-critical-devices"
  ["blog_url"]=>
  string(107) "https://www.assemblymag.com/articles/95567-hp-offers-3d-printing-to-increase-production-of-critical-devices"
  [15]=>
  string(19) "2020-03-26 00:51:45"
  ["add_date"]=>
  string(19) "2020-03-26 00:51:45"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:24:13"
  ["create_at"]=>
  string(19) "2020-03-31 11:24:13"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

HP Offers 3D Printing to Increase Production of Critical Devices

&#nl PALO ALTO, CA — HP Inc. and its global digital manufacturing community are mobilizing 3D printing tea

array(40) {
  [0]=>
  string(4) "8751"
  ["article_id"]=>
  string(4) "8751"
  [1]=>
  string(58) "Roche ups Actemra production anticipating increased demand"
  ["article_title"]=>
  string(58) "Roche ups Actemra production anticipating increased demand"
  [2]=>
  string(146) "Roche looks to maximize production of its arthritis treatment as the drug enters late-stage trials to evaluate its effectiveness against COVID-19."
  ["short_description"]=>
  string(146) "Roche looks to maximize production of its arthritis treatment as the drug enters late-stage trials to evaluate its effectiveness against COVID-19."
  [3]=>
  string(146) "Roche looks to maximize production of its arthritis treatment as the drug enters late-stage trials to evaluate its effectiveness against COVID-19."
  ["description"]=>
  string(146) "Roche looks to maximize production of its arthritis treatment as the drug enters late-stage trials to evaluate its effectiveness against COVID-19."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(3) "107"
  ["rss_id"]=>
  string(3) "107"
  [14]=>
  string(157) "https://www.biopharma-reporter.com/Article/2020/03/25/Roche-ups-Actemra-production-for-coronavirus-trials?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(157) "https://www.biopharma-reporter.com/Article/2020/03/25/Roche-ups-Actemra-production-for-coronavirus-trials?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-03-26 00:00:00"
  ["add_date"]=>
  string(19) "2020-03-26 00:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:24:19"
  ["create_at"]=>
  string(19) "2020-03-31 11:24:19"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Roche ups Actemra production anticipating increased demand

Roche looks to maximize production of its arthritis treatment as the drug enters late-stage trials to evaluate its effec

array(40) {
  [0]=>
  string(4) "8752"
  ["article_id"]=>
  string(4) "8752"
  [1]=>
  string(49) "BioStem adds R&D laboratory space to Florida site"
  ["article_title"]=>
  string(49) "BioStem adds R&D laboratory space to Florida site"
  [2]=>
  string(138) "BioStem announces expansion of its manufacturing facility to include an R&D laboratory to support its services for regenerative therapies."
  ["short_description"]=>
  string(138) "BioStem announces expansion of its manufacturing facility to include an R&D laboratory to support its services for regenerative therapies."
  [3]=>
  string(138) "BioStem announces expansion of its manufacturing facility to include an R&D laboratory to support its services for regenerative therapies."
  ["description"]=>
  string(138) "BioStem announces expansion of its manufacturing facility to include an R&D laboratory to support its services for regenerative therapies."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(3) "107"
  ["rss_id"]=>
  string(3) "107"
  [14]=>
  string(134) "https://www.biopharma-reporter.com/Article/2020/03/25/BioStem-expands-with-R-D-lab?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(134) "https://www.biopharma-reporter.com/Article/2020/03/25/BioStem-expands-with-R-D-lab?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-03-26 00:00:00"
  ["add_date"]=>
  string(19) "2020-03-26 00:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:24:19"
  ["create_at"]=>
  string(19) "2020-03-31 11:24:19"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

BioStem adds R&D laboratory space to Florida site

BioStem announces expansion of its manufacturing facility to include an R&D laboratory to support its services for regen

array(40) {
  [0]=>
  string(4) "8541"
  ["article_id"]=>
  string(4) "8541"
  [1]=>
  string(64) "Supermarkets urged to include pharmacists in NHS shopping hours "
  ["article_title"]=>
  string(64) "Supermarkets urged to include pharmacists in NHS shopping hours "
  [2]=>
  string(154) "The Royal Pharmaceutical Society has written to the major supermarket chains urging them to ensure that pharmacists can access dedicated shopping ti"
  ["short_description"]=>
  string(154) "The Royal Pharmaceutical Society has written to the major supermarket chains urging them to ensure that pharmacists can access dedicated shopping ti"
  [3]=>
  string(174) "The Royal Pharmaceutical Society has written to the major supermarket chains urging them to ensure that pharmacists can access dedicated shopping times for NHS workers."
  ["description"]=>
  string(174) "The Royal Pharmaceutical Society has written to the major supermarket chains urging them to ensure that pharmacists can access dedicated shopping times for NHS workers."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(142) "https://www.pharmaceutical-journal.com/news-and-analysis/news/supermarkets-urged-to-include-pharmacists-in-nhs-shopping-hours/20207853.article"
  ["blog_url"]=>
  string(142) "https://www.pharmaceutical-journal.com/news-and-analysis/news/supermarkets-urged-to-include-pharmacists-in-nhs-shopping-hours/20207853.article"
  [15]=>
  string(19) "2020-03-25 23:15:00"
  ["add_date"]=>
  string(19) "2020-03-25 23:15:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:18:02"
  ["create_at"]=>
  string(19) "2020-03-31 11:18:02"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Supermarkets urged to include pharmacists in NHS shopping hours

The Royal Pharmaceutical Society has written to the major supermarket chains urging them to ensure that pharmacists c

array(40) {
  [0]=>
  string(4) "8695"
  ["article_id"]=>
  string(4) "8695"
  [1]=>
  string(102) "Sidley Austin's EU MDR guidance on "significant" change and clinical evidence for software"
  ["article_title"]=>
  string(102) "Sidley Austin's EU MDR guidance on "significant" change and clinical evidence for software"
  [2]=>
  string(161) "Maurits Lugard, partner and Josefin Sommer, senior associate, in law firm Sidley Austin’s Global Life Sciences practice, updates on new EU MDR gu"
  ["short_description"]=>
  string(161) "Maurits Lugard, partner and Josefin Sommer, senior associate, in law firm Sidley Austin’s Global Life Sciences practice, updates on new EU MDR gu"
  [3]=>
  string(239) "Maurits Lugard, partner and Josefin Sommer, senior associate, in law firm Sidley Austin’s Global Life Sciences practice, updates on new EU MDR guidance on “significant” change and clinical evidence for software."
  ["description"]=>
  string(239) "Maurits Lugard, partner and Josefin Sommer, senior associate, in law firm Sidley Austin’s Global Life Sciences practice, updates on new EU MDR guidance on “significant” change and clinical evidence for software."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(70) "https://www.medicalplasticsnews.com/news/opinion/sidley-austin-eu-mdr/"
  ["blog_url"]=>
  string(70) "https://www.medicalplasticsnews.com/news/opinion/sidley-austin-eu-mdr/"
  [15]=>
  string(19) "2020-03-25 22:58:48"
  ["add_date"]=>
  string(19) "2020-03-25 22:58:48"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:40"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Sidley Austin's EU MDR guidance on "significant" change and clinical evidence

Maurits Lugard, partner and Josefin Sommer, senior associate, in law firm Sidley Austin’s Global Life Scien

array(40) {
  [0]=>
  string(4) "8600"
  ["article_id"]=>
  string(4) "8600"
  [1]=>
  string(71) "Sharps Compliance Provides Update on Continued Infrastructure Build Out"
  ["article_title"]=>
  string(71) "Sharps Compliance Provides Update on Continued Infrastructure Build Out"
  [2]=>
  string(166) "HOUSTON, March  25, 2020  (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service natio"
  ["short_description"]=>
  string(166) "HOUSTON, March  25, 2020  (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service natio"
  [3]=>
  string(474) "

HOUSTON, March 25, 2020 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service national provider of comprehensive waste management solutions including medical, pharmaceutical and hazardous, is providing an update on its continuing efforts to expand its infrastructure and strengthen its service capabilities, particularly in light of the COVID-19 pandemic. 

" ["description"]=> string(474) "

HOUSTON, March 25, 2020 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service national provider of comprehensive waste management solutions including medical, pharmaceutical and hazardous, is providing an update on its continuing efforts to expand its infrastructure and strengthen its service capabilities, particularly in light of the COVID-19 pandemic. 

" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "26" ["rss_id"]=> string(2) "26" [14]=> string(142) "http://www.globenewswire.com/news-release/2020/03/25/2006209/0/en/Sharps-Compliance-Provides-Update-on-Continued-Infrastructure-Build-Out.html" ["blog_url"]=> string(142) "http://www.globenewswire.com/news-release/2020/03/25/2006209/0/en/Sharps-Compliance-Provides-Update-on-Continued-Infrastructure-Build-Out.html" [15]=> string(19) "2020-03-25 20:30:00" ["add_date"]=> string(19) "2020-03-25 20:30:00" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2020-03-31 11:23:19" ["create_at"]=> string(19) "2020-03-31 11:23:19" [19]=> string(0) "" ["slug"]=> string(0) "" }

Sharps Compliance Provides Update on Continued Infrastructure Build Out

HOUSTON, March 25, 2020 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) (“Sha

array(40) {
  [0]=>
  string(4) "8480"
  ["article_id"]=>
  string(4) "8480"
  [1]=>
  string(55) "Bayer enlists Curadev in STING antagonist collaboration"
  ["article_title"]=>
  string(55) "Bayer enlists Curadev in STING antagonist collaboration"
  [2]=>
  string(99) "STING is known to play a role in activating the innate immune system in auto-inflammatory diseases."
  ["short_description"]=>
  string(99) "STING is known to play a role in activating the innate immune system in auto-inflammatory diseases."
  [3]=>
  string(99) "STING is known to play a role in activating the innate immune system in auto-inflammatory diseases."
  ["description"]=>
  string(99) "STING is known to play a role in activating the innate immune system in auto-inflammatory diseases."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "4"
  ["rss_id"]=>
  string(1) "4"
  [14]=>
  string(95) "http://www.pharmatimes.com/news/bayer_enlists_curadev_in_sting_antagonist_collaboration_1329995"
  ["blog_url"]=>
  string(95) "http://www.pharmatimes.com/news/bayer_enlists_curadev_in_sting_antagonist_collaboration_1329995"
  [15]=>
  string(19) "2020-03-25 19:57:52"
  ["add_date"]=>
  string(19) "2020-03-25 19:57:52"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:17:58"
  ["create_at"]=>
  string(19) "2020-03-31 11:17:58"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Bayer enlists Curadev in STING antagonist collaboration

STING is known to play a role in activating the innate immune system in auto-inflammatory diseases.

array(40) {
  [0]=>
  string(4) "8696"
  ["article_id"]=>
  string(4) "8696"
  [1]=>
  string(44) "Clariant expands polymer compounds portfolio"
  ["article_title"]=>
  string(44) "Clariant expands polymer compounds portfolio"
  [2]=>
  string(150) "The polymers announced by Clariant Plastics and Coatings Healthcare Polymer Solutions, offer both makers of medical devices and pharmaceutical packagi"
  ["short_description"]=>
  string(150) "The polymers announced by Clariant Plastics and Coatings Healthcare Polymer Solutions, offer both makers of medical devices and pharmaceutical packagi"
  [3]=>
  string(241) "The polymers announced by Clariant Plastics and Coatings Healthcare Polymer Solutions, offer both makers of medical devices and pharmaceutical packaging enhanced functionality, without compromising on compliance with regulatory requirements."
  ["description"]=>
  string(241) "The polymers announced by Clariant Plastics and Coatings Healthcare Polymer Solutions, offer both makers of medical devices and pharmaceutical packaging enhanced functionality, without compromising on compliance with regulatory requirements."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(86) "https://www.medicalplasticsnews.com/news/clariant-expands-polymer-compounds-portfolio/"
  ["blog_url"]=>
  string(86) "https://www.medicalplasticsnews.com/news/clariant-expands-polymer-compounds-portfolio/"
  [15]=>
  string(19) "2020-03-25 17:51:24"
  ["add_date"]=>
  string(19) "2020-03-25 17:51:24"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:40"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Clariant expands polymer compounds portfolio

The polymers announced by Clariant Plastics and Coatings Healthcare Polymer Solutions, offer both makers of medical devi

array(40) {
  [0]=>
  string(4) "8697"
  ["article_id"]=>
  string(4) "8697"
  [1]=>
  string(58) "Medovate to bring new endoscopic surgical device to market"
  ["article_title"]=>
  string(58) "Medovate to bring new endoscopic surgical device to market"
  [2]=>
  string(124) "Medical device company Medovate has secured the exclusive rights to bring to market a pioneering endoscopic surgical device."
  ["short_description"]=>
  string(124) "Medical device company Medovate has secured the exclusive rights to bring to market a pioneering endoscopic surgical device."
  [3]=>
  string(124) "Medical device company Medovate has secured the exclusive rights to bring to market a pioneering endoscopic surgical device."
  ["description"]=>
  string(124) "Medical device company Medovate has secured the exclusive rights to bring to market a pioneering endoscopic surgical device."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(100) "https://www.medicalplasticsnews.com/news/medovate-to-bring-new-endoscopic-surgical-device-to-market/"
  ["blog_url"]=>
  string(100) "https://www.medicalplasticsnews.com/news/medovate-to-bring-new-endoscopic-surgical-device-to-market/"
  [15]=>
  string(19) "2020-03-25 17:48:53"
  ["add_date"]=>
  string(19) "2020-03-25 17:48:53"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:40"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Medovate to bring new endoscopic surgical device to market

Medical device company Medovate has secured the exclusive rights to bring to market a pioneering endoscopic surgical dev